Prostaglandin receptor EP2 protects dopaminergic neurons against 6-OHDA-mediated low oxidative stress
- 6 June 2008
- journal article
- research article
- Published by Elsevier BV in Neuroscience Letters
- Vol. 441 (1), 44-49
- https://doi.org/10.1016/j.neulet.2008.05.111
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- PGE2 receptor EP1 renders dopaminergic neurons selectively vulnerable to low‐level oxidative stress and direct PGE2 neurotoxicityJournal of Neuroscience Research, 2007
- Lipid signaling: Sleep, synaptic plasticity, and neuroprotectionProstaglandins & Other Lipid Mediators, 2005
- Dopaminergic neurotoxicity by 6-OHDA and MPP+: Differential requirement for neuronal cyclooxygenase activityJournal of Neuroscience Research, 2005
- Microglial EP2 is critical to neurotoxicity from activated cerebral innate immunityGlia, 2005
- PGE2 receptors rescue motor neurons in a model of amyotrophic lateral sclerosisAnnals of Neurology, 2004
- Transcriptional regulation by the phosphorylation-dependent factor CREBNature Reviews Molecular Cell Biology, 2001
- Differentiative Effects of Dopamine on Striatal Neurons Involve Stimulation of the cAMP/PKA PathwayMolecular and Cellular Neuroscience, 1998
- Chronic Activation of the Cyclic AMP Signaling Pathway Promotes Development and Long‐Term Survival of Mesencephalic Dopaminergic NeuronsJournal of Neurochemistry, 1996
- Cyclic AMP, but not basic FGF, increases the in vitro survival of mesencephalic dopaminergic neurons and protects them from MPP+‐induced degenerationJournal of Neuroscience Research, 1992
- K-252 compounds, novel and potent inhibitors of protein kinase C and cyclic nucleotide-dependent protein kinasesBiochemical and Biophysical Research Communications, 1986